Results 11 to 20 of about 22,786 (211)

Ten-year outcome of anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration

open access: yesIndian Journal of Ophthalmology, 2021
Purpose: The aim of this study was to report the 10-year visual outcome in eyes treated with anti-vascular endothelial growth factor (anti-VEGF) agents for neovascular age-related macular degeneration (nAMD) and to assess the impact of switching ...
Deepa Upasani, Narendra Dhingra
doaj   +1 more source

Incidence and prevalence of neovascular age-related macular degeneration: 15-year epidemiological study in a population-based cohort in Finland

open access: yesAnnals of Medicine, 2023
Background/objectives Neovascular age-related macular degeneration (nAMD) is a common cause for visual impairment in the ageing population. An increasing number of nAMD patients causes significant health burden, although intravitreal anti-VEGF agents ...
Ida Korva-Gurung   +3 more
doaj   +1 more source

Implementation of accelerated molecular dynamics in NAMD [PDF]

open access: yesComputational Science & Discovery, 2011
Accelerated molecular dynamics (aMD) is an enhanced-sampling method that improves the conformational space sampling by reducing energy barriers separating different states of a system. Here we present the implementation of aMD in the parallel simulation program NAMD.
Yi, Wang   +3 more
openaire   +2 more sources

Collective variable-based calculations in NAMD [PDF]

open access: yesBiophysical Journal, 2009
The computational power of parallel clusters and supercomputers, and of the macromolecular simulation softwares typically used has been rapidly increasing in the recent years. One of the consequences is the higher demand for methods to analyze the dynamics and conformational space of biomolecular complexes.
Fiorin, Giacomo   +2 more
openaire   +1 more source

Molecular dynamics recipes for genome research [PDF]

open access: yes, 2017
Molecular dynamics (MD) simulation allows one to predict the time evolution of a system of interacting particles. It is widely used in physics, chemistry and biology to address specific questions about the structural properties and dynamical mechanisms ...
Biagini, Tommaso   +8 more
core   +1 more source

Integrative metabolome and lipidome analyses of plasma in neovascular macular degeneration

open access: yesHeliyon, 2023
Age-related macular degeneration (AMD) causes irreversible vision-loss among the elderly in industrial countries. Neovascular AMD (nAMD), which refers to late-stage AMD, is characterized by severe vision-threatening choroidal neovascularization (CNV ...
Tantai Zhao   +4 more
doaj   +1 more source

Main memory in HPC: do we need more, or could we live with less? [PDF]

open access: yes, 2017
An important aspect of High-Performance Computing (HPC) system design is the choice of main memory capacity. This choice becomes increasingly important now that 3D-stacked memories are entering the market.
Ayguadé Parra, Eduard   +8 more
core   +2 more sources

Anti-VEGF therapy of neovascular age-related macular degeneration: from randomized trials to routine clinical practice

open access: yesРоссийский офтальмологический журнал, 2019
Antivasoproliferative therapy is a revolutionary trend in the treatment of neovascular age-related macular degeneration (nAMD), as it is aimed at blocking growth factors of the newly formed vessels.
R. R. Fayzrakhmanov
doaj   +1 more source

Comparison of cytokine levels in the aqueous humor of polypoidal choroidal vasculopathy and neovascular age-related macular degeneration patients

open access: yesBMC Ophthalmology, 2020
Background The concentrations of cytokines in the aqueous humor from neovascular age-related macular degeneration (nAMD) and polypoidal choroidal vasculopathy (PCV) may vary. The study was conducted to compare various cytokine levels in the aqueous humor
Huiying Zhou   +3 more
doaj   +1 more source

Morphologic Criteria of Lesion Activity in Neovascular Age-Related Macular Degeneration: A Consensus Article [PDF]

open access: yes, 2017
Intravitreal antivascular endothelial growth factor drugs represent the current standard of care for neovascular age-related macular degeneration (nAMD).
Elena Gusson   +8 more
core   +1 more source

Home - About - Disclaimer - Privacy